...
首页> 外文期刊>Internal medicine. >Risk of Chronic Kidney Disease in Non-Obese Individuals with Clustering of Metabolic Factors: A Longitudinal Study
【24h】

Risk of Chronic Kidney Disease in Non-Obese Individuals with Clustering of Metabolic Factors: A Longitudinal Study

机译:具有代谢因子聚类的非肥胖个体的慢性肾脏疾病风险:一项纵向研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective The impact of the clustering of metabolic factors on chronic kidney disease (CKD) in non-obese individuals remains unclear. Methods We conducted a follow-up study of 23,894 Japanese adults (age, 18-69 years) who continuously received annual health examinations between 2000 and 2011. Obesity, high blood pressure, high triglycerides, low high-density lipoprotein (HDL) cholesterol and high fasting blood sugar were defined as metabolic factors, and CKD was defined as renal dysfunction (estimated glomerular filtration rate: 2) or proteinuria (dipstick test: ≥1+). The association between the clustering of metabolic factors and CKD was assessed based on the presence or absence of obesity using a Cox proportional hazard model. Results Of 2,867 subjects with ≥3 metabolic factors, 650 (22.7%) were non-obese. These individuals were older and had higher metabolic risks than their obese counterparts at baseline. Among the entire cohort of 23,894 subjects, 1,764 developed renal dysfunction and 904 developed proteinuria during an average follow-up period of 7.8 years. The cumulative incidence of renal dysfunction was higher (22.1% vs. 16.1%), whereas that of proteinuria was lower (10.5% vs. 14.4%), among the non-obese subjects with ≥3 metabolic factors than the obese subjects with ≥3 metabolic factors after 11 years. The adjusted relative risk (RR) (95% confidence interval) of renal dysfunction was 1.54 (1.34-1.77) and 1.67 (1.35-2.07) for the obese and non-obese subjects with ≥3 metabolic factors, respectively. Conclusion Non-obese subjects with ≥3 metabolic factors, who are missed based on the essential criterion of obesity for metabolic syndrome, may have an equal or slightly higher risk of renal dysfunction than obese subjects with ≥3 metabolic factors.
机译:目的代谢因子聚集对非肥胖个体慢性肾脏病(CKD)的影响尚不清楚。方法我们对23894名日本成年人(年龄在18-69岁之间)进行了随访研究,这些成年人在2000年至2011年期间连续接受了年度健康检查。肥胖,高血压,高甘油三酸酯,低高密度脂蛋白(HDL)胆固醇和高空腹血糖被定义为代谢因子,而CKD被定义为肾功能不全(估计肾小球滤过率:2 )或蛋白尿(试纸法:≥1+)。使用Cox比例风险模型,根据肥胖的存在与否评估代谢因子与CKD之间的关联。结果2867名代谢因子≥3的受试者中,有650名(22.7%)为非肥胖。这些人比基线肥胖者年龄更大,代谢风险更高。在23,894名受试者的整个队列中,平均随访时间为7.8年,其中1,764名发生了肾功能不全,而904名发生了蛋白尿。在代谢因子≥3的非肥胖受试者中,肾功能不全的累积发生率较高(22.1%对16.1%),而蛋白尿的累积率较低(10.5%对14.4%)。 11年后有代谢因子。对于代谢因子≥3的肥胖和非肥胖受试者,肾功能不全的校正相对危险度(RR)(95%置信区间)为1.54(1.34-1.77)和1.67(1.35-2.07)。结论根据代谢综合征肥胖的基本标准而被遗漏的,具有≥3个代谢因子的非肥胖受试者,与具有≥3个代谢因子的肥胖受试者相比,可能具有相同或略高的肾功能不全风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号